Method of variability optimization in pharmacokinetic data analysis

被引:6
|
作者
Grabowski, Tomasz [1 ]
Jaroszewski, Jerzy Jan [2 ]
Piotrowski, Walerian [3 ]
Sasinowska-Motyl, Magorzta [4 ]
机构
[1] Polpharma Biol, PL-80172 Gdansk, Poland
[2] Univ Warmia & Mazury, Dept Pharmacol & Toxicol, Fac Vet Med, PL-10718 Olsztyn, Poland
[3] Inst Cardiol, Dept Epidemiol Cardiovasc Dis Prevent & Hlth Prom, Biostat Lab, Warsaw, Poland
[4] Med Univ Warsaw, Dept Pharmacodynam, PL-00927 Warsaw, Poland
关键词
Standard deviation; Sampling; Variability; Pharmacokinetics; HIGHLY VARIABLE DRUGS; STANDARD-DEVIATION; PHARMACODYNAMICS; ABSORPTION; COMPOUND;
D O I
10.1007/s13318-013-0145-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For many drugs administered per os, high variability in the concentration-time (C-T) values from first sampling to the phase of distribution may cause difficulty in pharmacokinetic analysis. Therefore, the aim of this study was to propose a method of transformation of C-T data, which would allow significantly reducing the standard deviation (SD) value of observed concentrations, without a statistically significant influence on the value of the mean for each sampling point in group. In the presented study, the lowest value of relative standard deviation of concentrations observed in the elimination phase and the value of precision of the used analytical method, were used to optimize the arithmetic, geometric means, median, and the value of SD obtained after single oral administration of itraconazole in human subjects. Non-compartmental modeling was used to estimate pharmacokinetic parameters. The analysis of SD pharmacokinetic parameters after C-T value optimization indicated more than twice the lower value of SD. After transforming the itraconazole data, lower variability of concentration data gives more selective pharmacokinetics profile in absorption and early distribution phase.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [1] Method of variability optimization in pharmacokinetic data analysis
    Tomasz Grabowski
    Jerzy Jan Jaroszewski
    Walerian Piotrowski
    Małgorzta Sasinowska-Motyl
    European Journal of Drug Metabolism and Pharmacokinetics, 2014, 39 : 111 - 119
  • [2] Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
    Kang, Won-ho
    Lee, Jae-yeon
    Chae, Jung-woo
    Lee, Kyeong-Ryoon
    Baek, In-hwan
    Kim, Min-Soo
    Back, Hyun-moon
    Jung, Sangkeun
    Shaffer, Craig
    Savic, Rada
    Yun, Hwi-yeol
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 11
  • [3] Pattern Recognition in Pharmacokinetic Data Analysis
    Johan Gabrielsson
    Bernd Meibohm
    Daniel Weiner
    The AAPS Journal, 2016, 18 : 47 - 63
  • [4] Pattern Recognition in Pharmacokinetic Data Analysis
    Gabrielsson, Johan
    Meibohm, Bernd
    Weiner, Daniel
    AAPS JOURNAL, 2016, 18 (01): : 47 - 63
  • [5] Interindividual Variability in the Pharmacodynamic and Pharmacokinetic Characteristics of Recombinant Human Insulin and Insulin Aspart
    Li, Ting
    Liu, Hui
    Yu, Hongling
    Qiao, Jingtao
    Sun, Lisi
    Yu, Yerong
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 594 - +
  • [6] EXTENSION OF THE LOO-RIEGELMAN METHOD TO PHARMACOKINETIC DATA AT STEADY-STATE
    NUESCH, EA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (01) : 55 - 57
  • [7] Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis
    del Mar Fernandez de Gatta, Maria
    Santos Buelga, Dolores
    Sanchez Navarro, Amparo
    Dominguez-Gil, Alfonso
    Jose Garcia, Maria
    CLINICAL PHARMACOKINETICS, 2009, 48 (04) : 273 - 280
  • [8] A Novel Antibiotic, Rhodomyrtone: Pharmacokinetic Studies in a Murine Model and Optimization and Validation of High-Performance Liquid Chromatographic Method for Plasma Analysis
    Suwandecha, Tan
    Yingyongnarongkul, Boon-Ek
    Towtawin, Kanokkan
    Voravuthikunchai, Supayang Piyawan
    Sriwiriyajan, Somchai
    ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [9] Factors affecting pharmacokinetic variability of oral topotecan: a population analysis
    F Léger
    W J Loos
    J Fourcade
    R Bugat
    M Goffinet
    R H J Mathijssen
    J Verweij
    A Sparreboom
    E Chatelut
    British Journal of Cancer, 2004, 90 : 343 - 347
  • [10] Factors affecting pharmacokinetic variability of oral topotecan:: a population analysis
    Léger, F
    Loos, WJ
    Fourcade, J
    Bugat, R
    Goffinet, M
    Mathijssen, RHJ
    Verweij, J
    Sparreboom, A
    Chatelut, E
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 343 - 347